Who Paid My Doc
Openlabel Phase 1 Study of Sgnb7h4v for Solid Tumors
Research payments
$3,601,713
Through program year 2024, $3,601,713 in research payments was reported against Openlabel Phase 1 Study of Sgnb7h4v for Solid Tumors, across 313 payments, paid by Pfizer Inc..
- Paid by
- Pfizer Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $3,601,713 | 313 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Cesar Batista Orlando, FL Named on 94 payments
- Erika Hamilton Nashville, TN Named on 49 payments
- Jason Henry Denver, CO Named on 45 payments
- Jennifer Diamond Aurora, CO Named on 29 payments
- Nehal Lakhani Grand Rapids, MI Named on 25 payments
- Amita Patnaik San Antonio, TX Named on 20 payments
- Gerardo Colon-Otero Jacksonville, FL Named on 13 payments
- Justin Call West Valley City, UT Named on 11 payments
- Guru Sonpavde Orlando, FL Named on 9 payments
- Bert O Neil Indianapolis, IN Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.